SONT Insider Trading Activity and SEC Form 4 Filings
SONT insider trading summary
No open-market insider purchases or sales of Sontra Medical Corp (SONT) have been reported on SEC Form 4 in the past 12 months.
Latest SONT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 30, 2007 | Robert Langer | Director | Buy | $25K (250,000 @ $0.10) |
| Jan 30, 2007 | Gerard E Puorro | Director | Buy | $20K (200,000 @ $0.10) |
| Jan 30, 2007 | Harry Mitchell | Interim CEO | Buy | $5K (50,000 @ $0.10) |
| Jan 30, 2007 | Gary S Kohler | Director | Buy | $10K (100,000 @ $0.10) |
| Jan 30, 2007 | Michael Wigley | Director | Buy | $60K (600,000 @ $0.10) |
| Sep 6, 2005 | Michael Wigley | Director | Buy | $6K (5,000 @ $1.29) |
| Sep 6, 2005 | Michael Wigley | Director | Buy | $6K (5,000 @ $1.21) |
| Sep 2, 2005 | Michael Wigley | Director | Buy | $6K (5,000 @ $1.29) |
| Sep 2, 2005 | Michael Wigley | Director | Buy | $4K (3,500 @ $1.28) |
| Aug 31, 2005 | Michael Wigley | Director | Buy | $6K (5,000 @ $1.29) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.